Clinical trial

Investigating the Interaction Between Two Long-acting Reversible Methods of Contraception and Dolutegravir, a Treatment for HIV

NCT04910711

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record Dolutegravir Normalized identity: dolutegravirView linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Levonorgestrel implant Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Depo medroxyprogesterone acetate injection Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Investigating the Interaction Between Two Long-acting Reversible Methods of Contraception and Dolutegravir, a Treatment for HIV

Design: INTERVENTIONAL · Status: UNKNOWN · Phase: PHASE4

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2021-10-21

PhasePHASE4

Conditions

Human Immunodeficiency Virusunresolved

Contraceptionunresolved

ARTunresolved

Interventions

DolutegravirDRUG · verified · RxNorm: dolutegravir

Levonorgestrel implantDRUG

Depo medroxyprogesterone acetate injectionDRUG

Sponsors & collaborators

Botswana Harvard AIDS Institute Partnershiplead sponsor

University of Liverpoolcollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04910711 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.